Michael J. Mitchell
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery 19
- Immunology top 0.5%
- Immunotherapy and Immune Responses 17
- Pharmaceutical Science top 0.2%
- Biomedical Engineering top 0.2%
- Nanoplatforms for cancer theranostics 10
- Molecular Biology top 0.5%
- RNA Interference and Gene Delivery 74
- Advanced biosensing and bioanalysis techniques 35
- Lipid Membrane Structure and Behavior 12
-
- CAR-T cell therapy research 18
-
- Virus-based gene therapy research 15
- Co-authors
- Róbert LangerMargaret M. BillingsleyRebecca M. HaleyNicholas A. PeppasMarissa E. WechslerCarl H. JuneRachel RileyMichael R. King
- Journals
- Nano Letters (11 papers)Journal of Controlled Release (8 papers)Nature Communications (7 papers)
- Partner nations
- United StatesChinaBrazil
In The Last Decade
Michael J. Mitchell
157 papers receiving 16.6k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Biomaterials 3.8k
- Immunology 3.4k
- Pharmaceutical Science 842
- Biomedical Engineering 5.5k
- Molecular Biology 8.2k
Countries citing papers authored by Michael J. Mitchell
This map shows the geographic impact of Michael J. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Mitchell more than expected).
Fields of papers citing papers by Michael J. Mitchell
This network shows the impact of papers produced by Michael J. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Mitchell. The network helps show where Michael J. Mitchell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael J. Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 38 | |
| 8 | 2024 | 42 | |
| 9 | 2024 | 41 | |
| 10 | 2024 | 28 | |
| 11 | 2024 | 41 | |
| 12 | 2024 | 31 | |
| 13 | High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical modelsbreakdown → | 2024 | 83 |
| 14 | 2024 | 17 | |
| 15 | 2023 | 23 | |
| 16 | 2023 | 32 | |
| 17 | 2023 | 32 | |
| 18 | Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccinesbreakdown → | 2023 | 68 |
| 19 | 2022 | 13 | |
| 20 | 2020 | 175 |
About Michael J. Mitchell
Michael J. Mitchell is a scholar working on Biomaterials, Immunology and Molecular Biology, having authored 164 papers that have together received 16.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (74 papers), Advanced biosensing and bioanalysis techniques (35 papers), Nanoparticle-Based Drug Delivery (19 papers), CAR-T cell therapy research (18 papers), Immunotherapy and Immune Responses (17 papers), Virus-based gene therapy research (15 papers), Lipid Membrane Structure and Behavior (12 papers) and Nanoplatforms for cancer theranostics (10 papers). The work is most often cited by research in Biomaterials (3.8k citations), Immunology (3.4k citations) and Pharmaceutical Science (842 citations). Michael J. Mitchell has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include Róbert Langer, Margaret M. Billingsley, Rebecca M. Haley, Nicholas A. Peppas, Marissa E. Wechsler, Carl H. June, Rachel Riley, Michael R. King, Xuexiang Han and Drew Weissman. Their work appears in journals such as Nano Letters, Journal of Controlled Release, Nature Communications, ACS Nano and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.